deltatrials
Completed PHASE3 NCT00596700

Capsule Endoscopy Crohn's Disease Activity Index - Validation Multi Center Study

Sponsor: Assaf-Harofeh Medical Center

Updated 7 times since 2017 Last updated: Apr 28, 2014 Started: Jan 31, 2007 Primary completion: Jan 31, 2012 Completion: Jan 31, 2012

This PHASE3 trial investigates Crohn's Disease and is currently completed. Assaf-Harofeh Medical Center leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Aug 2018 — Jan 2021 [monthly]

    Completed PHASE3

Show 2 earlier versions
  1. Jun 2018 — Aug 2018 [monthly]

    Completed PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Assaf-Harofeh Medical Center
  • Hillel Yaffe Medical Center
  • Rabin Medical Center
  • Rambam Health Care Campus
  • US Department of Veterans Affairs
  • University of Athens
  • University of Magdeburg
Data source: Rabin Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • Dublin, Ireland
  • Hadera, Israel
  • Petah Tikva, Israel
  • Zrifin, Israel